Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global gelatin capsule market size was valued at USD 1,997 million in 2024. The market is projected to grow from an estimated USD 2,131 million in 2025 to USD 3,157 million by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% during the forecast period.
Gelatin capsules are pharmaceutical-grade shells derived primarily from animal collagen, used as a dosage form to enclose active pharmaceutical ingredients (APIs), vitamins, and supplements. They are favored in the industry for their excellent bioavailability, as they dissolve quickly and reliably in the stomach, ensuring precise drug delivery. This essential role in drug formulation makes them a cornerstone of the pharmaceutical and nutraceutical sectors.
The market growth is primarily fueled by the expanding pharmaceutical industry and rising consumer demand for nutraceuticals and over-the-counter (OTC) healthcare products. However, the market faces the challenge of increasing competition from plant-based, non-gelatin alternatives, driven by vegetarian and vegan consumer preferences. Despite this, the dominance of traditional gelatin capsules remains strong due to their superior technical properties and cost-effectiveness for mass production. The market is characterized by high consolidation, with the top five players, including industry leaders like Lonza (Capsugel) and ACG, accounting for approximately 70% of the global market share, highlighting a mature yet competitive landscape.
Increasing Demand from Pharmaceutical Sector
The global pharmaceutical industry's robust growth, driven by an aging population and rising incidence of chronic diseases, is a primary driver for the gelatin capsule market. Capsules are the preferred oral solid dosage form for many drugs due to their ease of swallowing, precise dosing, and ability to mask unpleasant tastes and odors. The expansion of over-the-counter (OTC) vitamin and supplement markets further amplifies this demand.
Advantages Over Alternative Delivery Forms
Gelatin capsules offer significant benefits compared to tablets and other forms. They provide faster disintegration and dissolution rates, leading to improved bioavailability of active ingredients. The manufacturing process for capsules is also generally more efficient and cost-effective for many formulations, requiring fewer excipients and no compression steps, which is attractive to drug manufacturers.
The global nutraceuticals market is projected to surpass $700 billion by 2030, creating a substantial and sustained demand for encapsulation solutions like gelatin capsules.
Consumer preference for halal, kosher, and non-GMO certified products is also influencing the market. Manufacturers are increasingly sourcing bovine and porcine gelatin from certified suppliers to meet these specific requirements, thereby capturing niche but growing market segments.
MARKET CHALLENGES
Competition from Non-Gelatin Alternatives
A significant challenge is the growing competition from plant-based and synthetic capsules, such as those made from hydroxypropyl methylcellulose (HPMC). These alternatives are gaining traction among vegetarian, vegan, and certain religious populations. Furthermore, HPMC capsules have better stability under low-humidity conditions, posing a technical challenge for standard gelatin capsules in specific climates and formulations.
Other Challenges
Supply Chain and Raw Material Volatility
The gelatin capsule market is dependent on the supply of raw materials, primarily bovine and porcine hides and bones. Fluctuations in the livestock industry, along with concerns about animal diseases like Bovine Spongiform Encephalopathy (BSE), can lead to supply instability and price volatility, impacting production costs and planning.
Regulatory Hurdles and Quality Standards
Stringent regulatory requirements from agencies like the FDA and EMA regarding the quality, safety, and traceability of raw materials present ongoing challenges. Compliance with Good Manufacturing Practices (GMP) and evolving pharmacopoeial standards requires continuous investment in quality control systems.
Cultural and Dietary Restrictions
The animal origin of traditional gelatin is a major restraint, limiting its acceptance among vegetarian, vegan, and specific religious communities (e.g., Hindu, Jain, Jewish, Islamic). This cultural barrier has directly fueled the development and adoption of non-animal-derived capsule shells, restraining the growth potential of the conventional gelatin capsule market in these consumer segments.
Inherent Stability Issues
Gelatin is hygroscopic and can become brittle in very dry conditions or soft and sticky in high-humidity environments. This sensitivity to moisture can lead to challenges in storage, packaging, and shelf-life for certain formulations, especially those containing hygroscopic active ingredients. This inherent property can restrict its use for drugs requiring very specific storage conditions.
Innovation in Specialized Formulations
There is a significant opportunity in developing advanced gelatin capsules for specialized drug delivery. This includes capsules designed for delayed-release, sustained-release, or targeted drug delivery to specific regions of the gastrointestinal tract. Such innovations can enhance therapeutic outcomes and create high-value products for pharmaceutical companies.
Expansion in Emerging Economies
Rapidly growing pharmaceutical markets in Asia-Pacific, Latin America, and Africa present substantial growth opportunities. Improving healthcare infrastructure, rising disposable incomes, and increasing government focus on healthcare accessibility in these regions are expected to drive the demand for affordable medicines, a large portion of which are delivered in capsule form.
Differentiation through Sourcing and Certification
Manufacturers can capitalize on opportunities by offering gelatin capsules from clearly defined and certified sources, such as bovine gelatin from BSE-free countries or fish gelatin. Obtaining halal, kosher, and other relevant certifications can help companies differentiate their products and access valuable niche markets globally.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Stomach-soluble Gelatin Capsules represent the dominant category due to their excellent bioavailability and rapid dissolution profile, which are crucial for immediate-release drug formulations and are favored for a vast majority of pharmaceutical applications. Enterosoluble capsules, designed to dissolve in the intestines, carve out a significant niche for active ingredients that require site-specific delivery or protection from stomach acid, supporting the trend towards more sophisticated drug delivery systems. The enduring preference for gelatin capsules is underpinned by their proven safety, consumer familiarity, and manufacturing efficiency compared to alternative materials, ensuring their sustained leadership for standard oral dosage forms. |
| By Application |
|
Pharmaceutical applications overwhelmingly drive demand for gelatin capsules, as they are the preferred encapsulation method for a wide array of prescription and over-the-counter drugs, including antibiotics, vitamins, and supplements. The versatility of capsules in accommodating various formulations, from powders to semi-solids, along with their ability to mask unpleasant tastes and odors, makes them indispensable in drug development. The healthcare products segment, encompassing dietary supplements and nutraceuticals, is a major growth area fueled by increasing health consciousness and consumer preference for convenient dosage forms, though it remains secondary to the vast and deeply entrenched pharmaceutical market. |
| By End User |
|
Pharmaceutical Companies constitute the primary customer base, leveraging gelatin capsules for their extensive drug portfolios and relying on their established supply chains and regulatory acceptance. These large-scale manufacturers demand high-volume, consistent quality capsules to support global distribution. Nutraceutical and supplement brands represent a dynamic and rapidly growing segment, driven by consumer trends and often requiring capsules for brand differentiation. Meanwhile, Contract Manufacturing Organizations are increasingly significant end users, as pharmaceutical and nutraceutical companies outsource production to specialized partners who require a reliable supply of capsules to fulfill diverse client formulations and batch sizes. |
| By Functionality |
|
Immediate Release functionality is the cornerstone of the gelatin capsule market, valued for its simplicity and effectiveness in ensuring rapid drug absorption for a multitude of therapeutic needs. Delayed release capsules, such as enteric-coated variants, are critical for protecting drugs from gastric acid or for targeting drug release in the intestinal tract, addressing specific clinical requirements. The market for modified release capsules, while more specialized, is expanding as pharmaceutical innovation focuses on enhancing patient compliance and therapeutic outcomes through controlled drug delivery profiles, representing a key area for future technological advancement and product differentiation. |
| By Capsule Size |
|
Standard Sizes like 00, 0, and 1 are the workhorses of the industry, offering the ideal capacity for most drug formulations while ensuring ease of swallowing for a broad patient population, making them the default choice for mass-market products. Smaller capsule sizes are essential for low-dose medications, pediatric formulations, and products where minimizing excipient content is a priority, catering to specific patient needs and niche applications. Specialty and elongated sizes are gaining prominence for their use in brand differentiation, combination therapies that require separate compartments, and for accommodating unique powder blends or mini-tablets, illustrating how capsule size is a strategic element in product design beyond mere volume capacity. |
A Consolidated Market Led by a Handful of Global Giants
The global gelatin capsule market is characterized by a high degree of consolidation, with the top five players collectively accounting for approximately 70% of the market share. This dominance is led by Lonza's Capsugel division, which stands as the undisputed global leader. Following closely are major players like Qualicaps and ACG Associated Capsules Pvt. Ltd. (ACPL), which have established extensive global manufacturing footprints and strong relationships with pharmaceutical clients. These leading companies have achieved their position through significant investments in advanced manufacturing technologies, consistent product quality, and vast distribution networks catering to the demanding pharmaceutical industry, the primary end-user of gelatin capsules.
Beyond the top-tier giants, the market includes several significant regional and specialized manufacturers that hold important niches. Companies such as Suheung in South Korea and Farmacapsulas SA in Latin America are key regional leaders. In China, a large number of manufacturers, including Dah Feng Capsule, Lefan Capsule, and Huangshan Capsule, contribute substantially to the Asia-Pacific market's supply. Other notable players like India's Nectar Lifesciences Ltd. and Erawat Pharma Limited, along with specialized firms such as Roxlor, provide competition and serve specific geographic or application-based segments, ensuring a diverse and dynamic competitive environment.
List of Key Gelatin Capsule Companies ProfiledCapsugel (Lonza)
Farmacapsulas SA
ERAWAT PHARMA LIMITED
Dah Feng Capsule
Lefan Capsule
Shing Lih Fang
Roxlor
Kangke
Angtai
Qinhai Gelatin Company
Huangshan Capsule
The global gelatin capsule market demonstrates robust growth, with its valuation increasing from approximately $1,997 million in 2024 to a projected $3,157 million by 2031, representing a compound annual growth rate (CAGR) of 6.9%. This consistent expansion is fundamentally driven by the essential role of gelatin capsules in the pharmaceutical industry. Their key advantages, including excellent bioavailability and the ability to dissolve quickly and reliably in the stomach, make them a preferred dosage form for a wide range of medications. The stability and consumer familiarity with this delivery system continue to solidify its position in the market.
Other TrendsMarket Consolidation and Regional Dynamics
The competitive landscape is characterized by a high degree of consolidation, with the top five manufacturers collectively holding about 70% of the global market share. Key players such as Lonza, Qualicaps, and ACG dominate the industry. Geographically, Europe is the largest market, accounting for approximately 35% of the global share, followed closely by North America and the Asia-Pacific region, which together represent about 55% of the market. This distribution highlights the concentration of pharmaceutical manufacturing and consumption in these developed and rapidly developing economies.
Product and Application Segmentation
In terms of product types, stomach-soluble gelatin capsules are the dominant segment, holding a significant share of about 75%. Their widespread use is attributed to their suitability for a majority of oral drug formulations. The enterosoluble vacant gelatin capsules and other types cater to more specialized pharmaceutical needs. Regarding application, the pharmaceutical industry is the largest end-user, with healthcare products representing the other major application segment. The demand from these sectors is the primary engine for market growth.
Future Outlook and Strategic ImperativesLooking forward, the market's growth trajectory is expected to continue, supported by expanding healthcare access, an aging global population, and the ongoing development of new pharmaceutical products. For companies in this space, strategic focus on innovation in capsule technology, ensuring a secure and ethical supply chain for raw materials, and navigating the competitive pressures from both established giants and emerging regional players will be critical for maintaining and growing market share. Adherence to stringent global regulatory standards remains a constant imperative for all participants.
Regional Analysis: Gelatin Capsule MarketNorth America
North America represents a mature yet highly significant market for gelatin capsules, characterized by stringent regulatory oversight from the FDA and a strong preference for high-quality, reliable pharmaceutical products. The region is a major consumer, driven by a well-established pharmaceutical industry, high healthcare expenditure, and a consumer base with a strong awareness of dietary supplements. While domestic production exists, there is a substantial reliance on imports, particularly from Asia-Pacific, to meet demand. The market dynamics are influenced by a trend towards premiumization, with demand for value-added capsules that offer enhanced functionalities, such as improved bioavailability or tamper-evidence. Furthermore, the presence of major pharmaceutical innovators and a robust generic drug market ensures consistent demand for gelatin capsules as a primary dosage form.
Europe
Europe is another key market with a sophisticated pharmaceutical sector and strict regulatory standards governed by the European Medicines Agency. The demand for gelatin capsules is steady, supported by a strong generics market and high consumption of vitamins and dietary supplements. A notable dynamic is the growing consumer interest in halal and kosher certified capsules, as well as vegetarian alternatives, prompting manufacturers to diversify their offerings. The region's focus on sustainability is also beginning to influence packaging and sourcing decisions within the supply chain. Despite being a net importer of empty capsules, Europe maintains a strong position due to its advanced manufacturing capabilities for high-value, specialized pharmaceutical products that utilize capsules as a delivery system.
South America
The gelatin capsule market in South America is experiencing gradual growth, primarily driven by improving economic conditions, expanding access to healthcare, and a growing generic drug industry. Brazil and Argentina are the most prominent markets within the region. Local production is present but often insufficient to meet domestic demand, leading to significant imports. Market dynamics are shaped by price sensitivity and a focus on cost-effective pharmaceutical solutions. Governments in the region are investing in healthcare infrastructure and promoting local pharmaceutical production, which is expected to boost the market for excipients like gelatin capsules over the long term, though the market remains highly dependent on global supply chains.
Middle East & Africa
The Middle East and Africa region presents a market with diverse and emerging potential. The Gulf Cooperation Council countries, with their higher purchasing power, represent a more developed segment with demand for imported premium pharmaceuticals and supplements. In contrast, Africa's market is largely driven by humanitarian aid, generic drug programs, and gradually improving local healthcare systems. A key dynamic across the region is the specific demand for halal-certified gelatin capsules, which creates a niche segment. The market is characterized by significant import dependency and challenges related to supply chain logistics and regulatory heterogeneity, but it offers long-term growth prospects as economic development and healthcare access continue to improve.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252031. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type (Stomach-soluble, Enterosoluble, Others)
By application (Pharmaceutical, Healthcare Products, Others)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies in capsule manufacturing
Automation and quality control innovations
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical companies
Nutraceutical manufacturers
Healthcare product developers
Capsule manufacturers and suppliers
Investors and industry analysts
-> Global gelatin capsule market was valued at USD 1,997 million in 2024 and is projected to reach USD 3,157 million by 2031.
-> Key players include Lonza (Capsugel), Qualicaps, ACG, Suheung, and Farmacapsulas SA, with top five companies holding about 70% market share.
-> The market is expected to grow at a CAGR of 6.9% during 2025-2031.
-> Europe is the largest market with about 35% share, followed by North America and Asia-Pacific.
-> Stomach-soluble capsules dominate with ~75% share, followed by enterosoluble capsules.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates